Single-cell RNA-seq (scRNA-seq) has spent the past decade maturing into a foundational technology. Over that time, the ...

Review the current valuation for 10x Genomics Inc Ordinary Shares - Class A (TXG:XNAS) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation information.

10x Genomics Inc Ordinary Shares - Class A 10x Genomics Inc Ordinary Shares - Class A TXG Stock XNAS Rating as of Jun 26, 2025 Download PDF More Actions ...

10x Genomics is down 22.4% since the beginning of the year, and at $11.01 per share, it is trading 53.1% below its 52-week high of $23.49 from August 2024. Investors who bought $1,000 worth of 10x ...

The heart is made up of many different kinds of cells, such as muscle, nerve, and blood vessel cells. In zebrafish, around 12 to 15 percent of these cells originate from a specific population of stem ...

Right or wrong, we still believe that we live in a world where traditional HPC simulation and modeling at high precision ...

Meteor Biotech’s SLACS platform isolates cells from tissue for multi-omics, advancing cancer, inflammation, and spatial ...

Q1 results, resolving litigation, but faces trade and NIH policy challenges. Click for my look at TXG stock prospects.

10x Genomics, Inc. (NASDAQ: TXG) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. It has announced a ...